Ellen B. Richstone - 17 Jun 2026 Form 4 Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Reporting relationship: Director
Issuer ticker: CGTX
Reported as of: 17 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Jun 2026, 17:12:53 UTC
Prior SEC filing: 01 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ John Brendan Doyle, Attorney-in-Fact

Key filing fact

Ellen B. Richstone filed Form 4 for COGNITION THERAPEUTICS INC (CGTX) on 22 Jun 2026.

Key facts

This page summarizes Ellen B. Richstone's Form 4 filing for COGNITION THERAPEUTICS INC (CGTX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 22 Jun 2026, 17:12.

Change

Previous filing in this sequence was filed on 01 Jul 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001281526 Primary reporting owner

RICHSTONE ELLEN B

Relationship: Director
Address: C/O COGNITION THERAPEUTICS INC, 2500 WESTCHESTER AVE., PURCHASE
Signature: /s/ John Brendan Doyle, Attorney-in-Fact
Signature date: 22 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGTX transaction

Common Stock

Award

Transaction value
Shares: +25,000
Change %: +43%
Price: $0.000000^*
Shares after: 83,500
Date: 17 Jun 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.